Clinical Trial Update: Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the combination of Bavencio (avelumab) and Inlyta (axitinib) in patients with recurrent gliobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BAVENCIO (AVELUMAB)
• INLYTA (AXITINIB)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Recurrent Glioblastoma (WHO-Grade IV Glioma) | Phase 2 | Status: COMPLETED